aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
DCVC Bio is a venture capital fund specializing in early-stage computational biology startups. The firm focuses on companies leveraging advances in genetic sequencing, artificial intelligence, and automation to transform life sciences technologies. Their investment interests span synthetic biology, medicine, and agriculture, with a particular emphasis on startups shaping the biochemical building blocks of the life sciences industry.
The fund's portfolio includes notable companies such as AbCellera Biologics, Chroma Medicine, and Pivot Bio. DCVC Bio has participated in numerous Series A rounds, as well as seed and Series B investments. The firm's approach combines deep technological expertise with a focus on startups poised to make significant impacts in their respective fields, supporting innovations that address critical challenges in healthcare, sustainability, and biotechnology.
Also Known As
Dcvc Bio LLC Management
Operating Status
Active
Dcvc Bio Address
Palo Alto,
California
94301
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts